• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Thursday, November 19, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Trump’s Deal Turns Sour as Voters Withdraw Support

    Trump’s Deal Turns Sour as Voters Withdraw Support

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Trump’s Deal Turns Sour as Voters Withdraw Support

    Trump’s Deal Turns Sour as Voters Withdraw Support

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Oceania Australia New Zealand

Vertex Announces Provisional Agreement With Pharmac For The Reimbursement Of TRIKAFTA®

by Theinsightpost
December 4, 2022
in New Zealand
0 0
0
Vertex Announces Provisional Agreement With Pharmac For The Reimbursement Of TRIKAFTA®


Sunday, 4 December 2022, 7:08 pm
Press Release: Vertex

Vertex Announces Provisional Agreement with
Pharmac for the reimbursement of TRIKAFTA®
(elexacaftor/tezacaftor/ivacaftor and ivacaftor) for
Patients With Cystic Fibrosis Ages 6 Years and Older With at
Least One
F508del
Mutation in the
CFTR
Gene

– Under this agreement, more than 360
New Zealanders with cystic fibrosis will have funded access
to Trikafta, including around 340 who will have reimbursed
access to a CFTR modulator therapy for the first time
–

Wellington – 4 November 2022 – Vertex
Pharmaceuticals today announced that it has reached a
provisional agreement with New Zealand’s medicines
purchasing agency, Pharmac, for the reimbursement of
TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor).
Following a public consultation period, the agreement will
cover eligible cystic fibrosis (CF) patients 6 years and
older who have at least one F508del mutation in the
cystic fibrosis transmembrane conductance regulator
(CFTR)
gene with access planned from 1 April
2023.

“Today’s announcement is a significant
milestone in ensuring New Zealanders living with cystic
fibrosis receive timely and sustainable access to Trikafta,
including children as young as six,” said Sabrina Barbic,
Senior Country Manager, Vertex Australia and New Zealand.
“We are pleased that Pharmac has recognised that every
eligible patient should have access and acknowledges the
value Trikafta can bring, not only to people living with
cystic fibrosis and their caregivers, but also the wider
society.”

Pharmac will now seek public consultation
on its proposal to fund Trikafta. We acknowledge this as an
important step in the process and are hopeful that patients
will have access to Trikafta as soon as possible.

On
finalisation of the process, New Zealand will join more than
thirty-five other countries – including Australia, Canada,
Denmark, Finland, Spain, Germany, Austria, Slovenia,
Croatia, France, Italy, and the United Kingdom – where
Trikafta is broadly reimbursed for eligible CF
patients.

About TRIKAFTA®
(elexacaftor/tezacaftor/ivacaftor and ivacaftor)

In
people with certain types of mutations in the CFTR gene, the
CFTR protein is not processed or folded normally within the
cell, and this can prevent the CFTR protein from reaching
the cell surface and functioning properly. TRIKAFTA®
(elexacaftor/tezacaftor/ivacaftor and ivacaftor) is an oral
medicine designed to increase the quantity and function of
the CFTR protein at the cell surface. Elexacaftor and
tezacaftor work together to increase the amount of mature
protein at the cell surface by binding to different sites on
the CFTR protein. Ivacaftor, which is known as a CFTR
potentiator, is designed to facilitate the ability of CFTR
proteins to transport salt and water across the cell
membrane. The combined actions of elexacaftor, tezacaftor
and ivacaftor help hydrate and clear mucus from the
airways.

About TRIKAFTA®
(elexacaftor/tezacaftor/ivacaftor and ivacaftor) in New
Zealand

TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor
and ivacaftor) is a prescription medicine approved for the
treatment of cystic fibrosis (CF) in patients ages 6 years
and older who have at least one copy of
theF508delmutation in the CFTR gene.
TRIKAFTA has risks and benefits. Use strictly as directed.
TRIKAFTA is currently an unfunded medicine – a prescription
charge will apply.

  • Consumer Medicine information
    can be obtained from the Medsafe website www.medsafe.govt.nz
  • Prescribing
    Information (TRIKAFTA New Zealand Data Sheet) for healthcare
    professionals can be obtained from the Medsafe website www.medsafe.govt.nz

About
Cystic Fibrosis

Cystic fibrosis (CF) is a rare,
life-shortening genetic disease affecting more than 80,000
people globally. CF is a progressive, multi-system disease
that affects the lungs, liver, GI tract, sinuses, sweat
glands, pancreas and reproductive tract. CF is caused by a
defective and/or missing CFTR protein resulting from certain
mutations in the CFTR gene. Children must inherit two
defective CFTR genes — one from each parent — to
have CF. While there are many different types of CFTR
mutations that can cause the disease, the vast majority of
all people with CF have at least one F508del
mutation. These mutations, which can be determined by a
genetic test, or genotyping test, lead to CF by creating
non-working and/or too few CFTR proteins at the cell
surface. The defective function and/or absence of CFTR
protein results in poor flow of salt and water into and out
of the cells in a number of organs. In the lungs, this leads
to the buildup of abnormally thick, sticky mucus that can
cause chronic lung infections and progressive lung damage in
many patients that eventually leads to death. The median age
of death is in the early 30s.

About
Vertex

Vertex is a global biotechnology company that
invests in scientific innovation to create transformative
medicines for people with serious diseases. The company has
multiple approved medicines that treat the underlying cause
of cystic fibrosis (CF) — a rare, life-threatening genetic
disease — and has several ongoing clinical and research
programs in CF. Beyond CF, Vertex has a robust pipeline of
investigational small molecule, cell and genetic therapies
in other serious diseases where it has deep insight into
causal human biology, including sickle cell disease, beta
thalassemia, APOL1-mediated kidney disease, pain, type 1
diabetes, alpha-1 antitrypsin deficiency and Duchenne
muscular dystrophy.

Founded in 1989 in Cambridge,
Mass., Vertex’s global headquarters is now located in
Boston’s Innovation District and its international
headquarters is in London. Additionally, the company has
research and development sites and commercial offices in
North America, Europe, Australia and Latin America. Vertex
is consistently recognized as one of the industry’s top
places to work, including 13 consecutive years on Science
magazine’s Top Employers list and one of Fortune’s Best
Workplaces in Biotechnology and Pharmaceuticals and Best
Workplaces for
Women.

© Scoop Media






Join Scoop Citizen

Scoop is a champion of independent journalism and open publishing – informing New Zealanders through straight-talking independent journalism, and publishing news from a wide range of sectors. Join us and support the publication of trustworthy, relevant, public interest news, freely accessible to all New Zealanders:

Become a member
Find out more

Find more from Vertex on InfoPages.

 



Source link

ShareTweetSend
Previous Post

Ascot Capital’s Nedlands project approved

Next Post

Black Immigrant Daily News

Related News

Anthropic Launches Historic IPO, Soaring to New Heights in Market Value
New Zealand

Anthropic Launches Historic IPO, Soaring to New Heights in Market Value

November 19, 2026
Authorities Respond to Firearms Incident in West Melton, Canterbury
New Zealand

Authorities Respond to Firearms Incident in West Melton, Canterbury

November 19, 2026
Are Media Experiences Remarkable Growth in Readership for Its Leading Magazine Titles
New Zealand

Are Media Experiences Remarkable Growth in Readership for Its Leading Magazine Titles

November 19, 2026
Police Recovery: Firearm and Drug Paraphernalia Discovered in Vehicle Following Driver’s Evasion Attempt
New Zealand

Police Recovery: Firearm and Drug Paraphernalia Discovered in Vehicle Following Driver’s Evasion Attempt

November 18, 2026
Next Post
Black Immigrant Daily News

Black Immigrant Daily News

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Putin Promises Consequences Following Ukraine’s Assault on Kerch Strait Bridge

      Putin Promises Consequences Following Ukraine’s Assault on Kerch Strait Bridge

      November 19, 2026
      Brian Blessed Shares Amusing Encounter with Female Gorillas at Zoo

      Brian Blessed Shares Amusing Encounter with Female Gorillas at Zoo

      November 19, 2026
      Unveiling the Real Narrative: ‘The Altruists’ and Their Connection to the FTX Controversy

      Unveiling the Real Narrative: ‘The Altruists’ and Their Connection to the FTX Controversy

      November 19, 2026
      Is Hakeem Jeffries Facing a Moment of Crisis?

      Is Hakeem Jeffries Facing a Moment of Crisis?

      November 19, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy